Transmembrane protein 176B regulates amino acid metabolism through the PI3K-Akt-mTOR signaling pathway and promotes gastric cancer progression

Abstract Background The present study aimed to investigate the expression level, biological function, and underlying mechanism of transmembrane protein 176B (TMEM176B) in gastric cancer (GC). Methods TMEM176B expression was detected by quantitative real-time polymerase chain reaction (qRT-PCR) and w...

Full description

Bibliographic Details
Main Authors: Jing Li, ZiQing Fang, Emre Dal, Hao Zhang, KeXun Yu, MengDi Ma, MingLiang Wang, Ruochuan Sun, MingDian Lu, HuiZhen Wang, YongXiang Li
Format: Article
Language:English
Published: BMC 2024-03-01
Series:Cancer Cell International
Subjects:
Online Access:https://doi.org/10.1186/s12935-024-03279-4
_version_ 1797273179255734272
author Jing Li
ZiQing Fang
Emre Dal
Hao Zhang
KeXun Yu
MengDi Ma
MingLiang Wang
Ruochuan Sun
MingDian Lu
HuiZhen Wang
YongXiang Li
author_facet Jing Li
ZiQing Fang
Emre Dal
Hao Zhang
KeXun Yu
MengDi Ma
MingLiang Wang
Ruochuan Sun
MingDian Lu
HuiZhen Wang
YongXiang Li
author_sort Jing Li
collection DOAJ
description Abstract Background The present study aimed to investigate the expression level, biological function, and underlying mechanism of transmembrane protein 176B (TMEM176B) in gastric cancer (GC). Methods TMEM176B expression was detected by quantitative real-time polymerase chain reaction (qRT-PCR) and western blotting (WB). The function of TMEM176B was determined by various in vitro assays including colony formation, 5-ethynyl-2ʹ-deoxyuridine (EdU), Transwell, and flow cytometry. Bioinformatics techniques were then used to elucidate the signaling pathways associated with TMEM176B activity. Tumor formation experiments were conducted on nude mice for in vivo validation of the preceding findings. TMEM176B expression was cross-referenced to clinicopathological parameters and survival outcomes. Results It was observed that TMEM176B was overexpressed in GC cells and tissues. Targeted TMEM176B abrogation inhibited colony formation, proliferation, migration, and invasion but promoted apoptosis in GC cell lines while TMEM176B overexpression had the opposite effects. Subsequent experimental validation disclosed an association between TMEM176B and the phosphatidylinositol 3-carboxykinase (PI3K)-protein kinase B (Akt)-mammalian target of rapamycin (mTOR) signaling axis. Moreover, TMEM176B affects GC cancer progression by regulating asparagine synthetase (ASNS). The in vivo assays confirmed that TMEM176B is oncogenic and the clinical data revealed a connection between TMEM176B expression and the clinicopathological determinants of GC. Conclusion The foregoing results suggest that TMEM176B significantly promotes the development of gastric cancer and is an independent prognostic factor of it.
first_indexed 2024-03-07T14:39:54Z
format Article
id doaj.art-912c0935105c4ebcaa85505291b75484
institution Directory Open Access Journal
issn 1475-2867
language English
last_indexed 2024-03-07T14:39:54Z
publishDate 2024-03-01
publisher BMC
record_format Article
series Cancer Cell International
spelling doaj.art-912c0935105c4ebcaa85505291b754842024-03-05T20:25:26ZengBMCCancer Cell International1475-28672024-03-0124111510.1186/s12935-024-03279-4Transmembrane protein 176B regulates amino acid metabolism through the PI3K-Akt-mTOR signaling pathway and promotes gastric cancer progressionJing Li0ZiQing Fang1Emre Dal2Hao Zhang3KeXun Yu4MengDi Ma5MingLiang Wang6Ruochuan Sun7MingDian Lu8HuiZhen Wang9YongXiang Li10Department of General Surgery, The First Affiliated Hospital of Anhui Medical UniversityDepartment of General Surgery, The First Affiliated Hospital of Anhui Medical UniversityUniversity of UtahDepartment of General Surgery, The First Affiliated Hospital of Anhui Medical UniversityDepartment of General Surgery, The First Affiliated Hospital of Anhui Medical UniversityDepartment of General Surgery, The First Affiliated Hospital of Anhui Medical UniversityDepartment of General Surgery, The First Affiliated Hospital of Anhui Medical UniversityDepartment of General Surgery, The First Affiliated Hospital of Anhui Medical UniversityDepartment of General Surgery, The First Affiliated Hospital of Anhui Medical UniversityDepartment of General Surgery, The First Affiliated Hospital of Anhui Medical UniversityDepartment of General Surgery, The First Affiliated Hospital of Anhui Medical UniversityAbstract Background The present study aimed to investigate the expression level, biological function, and underlying mechanism of transmembrane protein 176B (TMEM176B) in gastric cancer (GC). Methods TMEM176B expression was detected by quantitative real-time polymerase chain reaction (qRT-PCR) and western blotting (WB). The function of TMEM176B was determined by various in vitro assays including colony formation, 5-ethynyl-2ʹ-deoxyuridine (EdU), Transwell, and flow cytometry. Bioinformatics techniques were then used to elucidate the signaling pathways associated with TMEM176B activity. Tumor formation experiments were conducted on nude mice for in vivo validation of the preceding findings. TMEM176B expression was cross-referenced to clinicopathological parameters and survival outcomes. Results It was observed that TMEM176B was overexpressed in GC cells and tissues. Targeted TMEM176B abrogation inhibited colony formation, proliferation, migration, and invasion but promoted apoptosis in GC cell lines while TMEM176B overexpression had the opposite effects. Subsequent experimental validation disclosed an association between TMEM176B and the phosphatidylinositol 3-carboxykinase (PI3K)-protein kinase B (Akt)-mammalian target of rapamycin (mTOR) signaling axis. Moreover, TMEM176B affects GC cancer progression by regulating asparagine synthetase (ASNS). The in vivo assays confirmed that TMEM176B is oncogenic and the clinical data revealed a connection between TMEM176B expression and the clinicopathological determinants of GC. Conclusion The foregoing results suggest that TMEM176B significantly promotes the development of gastric cancer and is an independent prognostic factor of it.https://doi.org/10.1186/s12935-024-03279-4Asparagine synthetaseGastric cancerMammalian target of rapamycinPhosphoinositide 3-kinaseProtein kinase BTransmembrane protein 176B
spellingShingle Jing Li
ZiQing Fang
Emre Dal
Hao Zhang
KeXun Yu
MengDi Ma
MingLiang Wang
Ruochuan Sun
MingDian Lu
HuiZhen Wang
YongXiang Li
Transmembrane protein 176B regulates amino acid metabolism through the PI3K-Akt-mTOR signaling pathway and promotes gastric cancer progression
Cancer Cell International
Asparagine synthetase
Gastric cancer
Mammalian target of rapamycin
Phosphoinositide 3-kinase
Protein kinase B
Transmembrane protein 176B
title Transmembrane protein 176B regulates amino acid metabolism through the PI3K-Akt-mTOR signaling pathway and promotes gastric cancer progression
title_full Transmembrane protein 176B regulates amino acid metabolism through the PI3K-Akt-mTOR signaling pathway and promotes gastric cancer progression
title_fullStr Transmembrane protein 176B regulates amino acid metabolism through the PI3K-Akt-mTOR signaling pathway and promotes gastric cancer progression
title_full_unstemmed Transmembrane protein 176B regulates amino acid metabolism through the PI3K-Akt-mTOR signaling pathway and promotes gastric cancer progression
title_short Transmembrane protein 176B regulates amino acid metabolism through the PI3K-Akt-mTOR signaling pathway and promotes gastric cancer progression
title_sort transmembrane protein 176b regulates amino acid metabolism through the pi3k akt mtor signaling pathway and promotes gastric cancer progression
topic Asparagine synthetase
Gastric cancer
Mammalian target of rapamycin
Phosphoinositide 3-kinase
Protein kinase B
Transmembrane protein 176B
url https://doi.org/10.1186/s12935-024-03279-4
work_keys_str_mv AT jingli transmembraneprotein176bregulatesaminoacidmetabolismthroughthepi3kaktmtorsignalingpathwayandpromotesgastriccancerprogression
AT ziqingfang transmembraneprotein176bregulatesaminoacidmetabolismthroughthepi3kaktmtorsignalingpathwayandpromotesgastriccancerprogression
AT emredal transmembraneprotein176bregulatesaminoacidmetabolismthroughthepi3kaktmtorsignalingpathwayandpromotesgastriccancerprogression
AT haozhang transmembraneprotein176bregulatesaminoacidmetabolismthroughthepi3kaktmtorsignalingpathwayandpromotesgastriccancerprogression
AT kexunyu transmembraneprotein176bregulatesaminoacidmetabolismthroughthepi3kaktmtorsignalingpathwayandpromotesgastriccancerprogression
AT mengdima transmembraneprotein176bregulatesaminoacidmetabolismthroughthepi3kaktmtorsignalingpathwayandpromotesgastriccancerprogression
AT mingliangwang transmembraneprotein176bregulatesaminoacidmetabolismthroughthepi3kaktmtorsignalingpathwayandpromotesgastriccancerprogression
AT ruochuansun transmembraneprotein176bregulatesaminoacidmetabolismthroughthepi3kaktmtorsignalingpathwayandpromotesgastriccancerprogression
AT mingdianlu transmembraneprotein176bregulatesaminoacidmetabolismthroughthepi3kaktmtorsignalingpathwayandpromotesgastriccancerprogression
AT huizhenwang transmembraneprotein176bregulatesaminoacidmetabolismthroughthepi3kaktmtorsignalingpathwayandpromotesgastriccancerprogression
AT yongxiangli transmembraneprotein176bregulatesaminoacidmetabolismthroughthepi3kaktmtorsignalingpathwayandpromotesgastriccancerprogression